The Center for Inquiry encourages FDA to look at the Federal Trade Commission enforcement policy requiring disclaimers for OTC homeopathic drugs' unsubstantiated claims as "the right decision to hold manufacturers accountable."
In a Nov. 16 statement on the FTC policy published Nov. 15, the group that promotes scientific evaluation...